Targeted News Service

European Society of Cardiology: Beta-blockers Did Not Reduce Cardiovascular Events in Selected Heart Attack Patients in the REBOOT Trial
August 30, 2025

SOPHIA ANTIPOLIS, France, Aug. 30 -- The European Society of Cardiology issued the following news release:

* * *

Beta-blockers did not reduce cardiovascular events in selected heart attack patients in the REBOOT trial

* While beta-blockers are a foundational treatment after acute myocardial infarction (MI) in patients with reduced left ventricular ejection fraction (LVEF), their role in patients with mildly reduced or preserved LVEF (>40%) is less certai . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form